US Archives - Page 82 of 149 - European Medical Journal

Parkinson’s Symptoms Improved in TEMPO-2 Trial: AAN 2025

New results from the Phase III TEMPO-2 trial, presented at the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, indicate that flexible-dose tavapadon significantly improved motor symptoms and daily functioning in adults with early Parkinson’s disease (PD), compared with placebo.

AAD 2025 Interview: Lindsay Ackerman

It’s phenomenally satisfying to see the investments that the industry has made in trying to continue to move the needle forward in the…

Patient Decision Aids Impact Skin Cancer Choices

A new study on superficial basal cell carcinoma treatment decisions highlights that patient decision aids may subtly shift treatment preferences, with keywords such as superficial basal cell carcinoma, patient decision aid, non-invasive treatment, and effective decision-making underscoring the research.

Lorazepam Treatment Enhanced by Phenobarbital in Alcohol Withdrawal Syndrome Outcomes

In hospitalized patients with alcohol withdrawal syndrome (AWS), early addition of phenobarbital to lorazepam-based treatment significantly reduces the length of stay and the need for mechanical ventilation compared to dexmedetomidine, according to a new retrospective study conducted in a U.S. tertiary hospital.

Can Genomic Testing Improve Your Melanoma Management?

This infographic explores how genomic testing, specifically the 31-GEP test, can enhance melanoma management by providing personalized risk…

Hand Sanitizers: Where They Work, and Where They Don't

Foam hand sanitizers are widely used in healthcare settings, but a recent study indicates their effectiveness may vary depending on the type of virus they’re targeting.

Skin Thickening Rate Signals Cardiopulmonary Risk

A new prospective cohort study has found that the rate of skin thickening progression in patients with systemic sclerosis (SSc), measured using the modified Rodnan skin score (mRSS), is closely correlated with the early onset of serious cardiopulmonary complications, including interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH).

New Stroke Risk Trend Emerges in Younger Adults: AAN 2025

At the 2025 American Academy of Neurology (AAN) Annual Meeting, researchers presented compelling new data showing a sharp increase in hospitalizations for cervical artery dissection, a potentially life-threatening cause of stroke, particularly in adults under 50.

Phase III Lung Cancer Trial Terminated Due to Futility

A major phase 3 lung cancer trial investigating the TGIT-targeting immunotherapy ociperlimab has been halted after interim analysis indicated it would not meet its primary endpoint of overall survival.

Luteal Phase Heightens Avoidance Responses

The menstrual cycle significantly impacts women’s emotional decision-making and cognitive processing, according to a new EEG study examining approach-avoidance behaviors across different hormonal phases.